Metis Global Partners LLC Reduces Stock Position in Cigna Group $CI

Metis Global Partners LLC trimmed its holdings in Cigna Group (NYSE:CI) by 9.9% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 12,044 shares of the health services provider’s stock after selling 1,318 shares during the quarter. Metis Global Partners LLC’s holdings in Cigna Group were worth $3,982,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Penserra Capital Management LLC boosted its position in Cigna Group by 8.8% during the second quarter. Penserra Capital Management LLC now owns 1,470 shares of the health services provider’s stock valued at $485,000 after buying an additional 119 shares during the period. Vestmark Advisory Solutions Inc. lifted its stake in shares of Cigna Group by 239.0% in the 2nd quarter. Vestmark Advisory Solutions Inc. now owns 2,244 shares of the health services provider’s stock valued at $742,000 after acquiring an additional 1,582 shares during the last quarter. Bryn Mawr Trust Advisors LLC boosted its holdings in Cigna Group by 7.5% during the 2nd quarter. Bryn Mawr Trust Advisors LLC now owns 962 shares of the health services provider’s stock valued at $318,000 after acquiring an additional 67 shares during the period. Savant Capital LLC grew its position in Cigna Group by 6.9% during the 2nd quarter. Savant Capital LLC now owns 15,701 shares of the health services provider’s stock worth $5,190,000 after acquiring an additional 1,009 shares during the last quarter. Finally, OneAscent Wealth Management LLC increased its stake in Cigna Group by 4.5% in the 2nd quarter. OneAscent Wealth Management LLC now owns 1,096 shares of the health services provider’s stock worth $362,000 after purchasing an additional 47 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on CI shares. Guggenheim lowered their price objective on Cigna Group from $350.00 to $309.00 in a research report on Friday, October 31st. Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday, October 8th. Cowen restated a “buy” rating on shares of Cigna Group in a research report on Tuesday. JPMorgan Chase & Co. lowered their price objective on shares of Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a research note on Tuesday, November 4th. Finally, Wells Fargo & Company cut their target price on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and an average price target of $339.73.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO David Cordani acquired 4,134 shares of Cigna Group stock in a transaction that occurred on Monday, November 3rd. The shares were bought at an average cost of $241.88 per share, with a total value of $999,931.92. Following the transaction, the chief executive officer owned 157,935 shares in the company, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 0.70% of the company’s stock.

Cigna Group Price Performance

Shares of CI stock opened at $264.54 on Friday. The business’s fifty day moving average is $293.24 and its 200 day moving average is $303.54. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a market cap of $70.66 billion, a price-to-earnings ratio of 14.44, a PEG ratio of 0.88 and a beta of 0.44. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. The firm had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be issued a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio is 26.64%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.